Plain-English translation of NCT04670666 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 2 Diabetes Mellitus research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a medication called Madalena, which combines three different drugs designed to help control blood sugar in people with type 2 diabetes. You would be randomly assigned to take either Madalena or a comparison treatment that combines three separate existing diabetes medications. The study will measure how well each treatment works and how safe it is.
Many people with type 2 diabetes don't reach healthy blood sugar levels even when taking two or more medications. This trial is exploring whether the new medication combination offers a better or more convenient option than taking the existing drugs separately.
You likely qualify if…
You likely don't qualify if…
You would take one tablet by mouth once daily, though you may receive additional placebo tablets to keep everyone blinded as to which treatment they're receiving. The study involves regular visits where your blood sugar will be checked and your health monitored. You'll need to complete screening tests first to confirm you qualify, and then continue in the trial for several months while researchers track how well the treatment works and any side effects you may experience.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
Brazil